ID   JFCF-6/T.1P
AC   CVCL_RW27
SY   JFCF-6/T.1/P
DR   Wikidata; Q54898592
RX   PubMed=19935656;
RX   PubMed=26001292;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4418 ! JFCF-6
SX   Male
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=19935656; DOI=10.1038/nbt.1587;
RA   Henson J.D., Cao Y., Huschtscha L.I., Chang A.C.-M., Au A.Y.M.,
RA   Pickett H.A., Reddel R.R.;
RT   "DNA C-circles are specific and quantifiable markers of
RT   alternative-lengthening-of-telomeres activity.";
RL   Nat. Biotechnol. 27:1181-1185(2009).
//
RX   PubMed=26001292; DOI=10.18632/oncotarget.3846; PMCID=PMC4599288;
RA   Napier C.E., Huschtscha L.I., Harvey A., Bower K., Noble J.R.,
RA   Hendrickson E.A., Reddel R.R.;
RT   "ATRX represses alternative lengthening of telomeres.";
RL   Oncotarget 6:16543-16558(2015).
//